- Dolutegravir for Children living with HIV
- ODYSSEY trial plays an important role in the FDA approval of dolutegravir for children – a big step towards timely access to optimal ART for children.
- What does COVID-19 mean for those living in HIV communities?
- ODYSSEY trial: COVID-19 response and CROI update
- Adeqaute dolutegravir exposure dosed BID with rifampicin in children 6 to < 18 years